HER2-regulated RNA as a diagnostic and therapeutic targets in HER2+ breast cancer
US10961589B2 · kind B2 · utility
2Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2016 |
| Grant date | Mar 30, 2021 |
| Priority date | — |
| Expiry date | Mar 7, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method for treating HER2 positive breast cancer in a subject in need thereof includes administering to cancer cells of the subject an agent effective to modulate the level of HER2-associated RNA in the breast cancer cells of the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.